|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | - |
| 21-10-27 | Patient Access Solutions, Inc. Introduces CAMEO | CI |
| 21-08-24 | Cara Therapeutics Shares Rise 7% on FDA Approval of Korsuva Injection | DJ |
| Market Cap | 350K 306K 281K 262K 497K 33.31M 504K 3.37M 1.31M 16.37M 1.31M 1.28M 56.42M | P/E 2007 * |
-
| P/E 2008 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 1.39M 1.21M 1.11M 1.04M 1.97M 132M 2M 13.36M 5.19M 64.84M 5.2M 5.09M 223M | EV / Sales 2007 * |
-
| EV / Sales 2008 | 24.4x |
| Free-Float |
-
| Yield 2007 * |
-
| Yield 2008 | - |
| 1 month | 0 | 0 | |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0 | |
| 5 years | 0 | 0.01 | |
| 10 years | 0 | 0.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bruce Weitzberg
CEO | Chief Executive Officer | 66 | - |
Robert Linzalone
PRN | Corporate Officer/Principal | 66 | 2010-02-01 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-14 | Other | 0 | 0% | |||
| 04-14 | Other | 0 | 0% | |||
| 04-14 | Other | 0 | 0% |
| 2007 | 2008 | |
|---|---|---|
| Net sales | 323K 282K 259K 242K 458K 30.72M 465K 3.11M 1.21M 15.1M 1.21M 1.19M 52.04M | 350K 306K 281K 262K 498K 33.36M 505K 3.38M 1.31M 16.4M 1.32M 1.29M 56.51M |
| Net income | -685K -599K -551K -513K -973K -65.25M -988K -6.61M -2.57M -32.07M -2.57M -2.52M -111M | -9.09M -7.95M -7.3M -6.81M -12.91M -866M -13.11M -87.67M -34.08M -425M -34.12M -33.39M -1.47B |
| Net Debt | 1.27M 1.11M 1.02M 954K 1.81M 121M 1.84M 12.29M 4.78M 59.62M 4.78M 4.68M 205M | 1.04M 905K 832K 776K 1.47M 98.61M 1.49M 9.99M 3.88M 48.47M 3.89M 3.8M 167M |
Employees
5
Sector
-
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- PASO Stock
Select your edition
All financial news and data tailored to specific country editions
















